Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Land a fertile field for historians
2017-12-25


 Description: Dr Admire Mseba Tags: Dr Admire Mseba 

Dr Admire Mseba, historian and researcher in the International Studies Group (ISG).
Photo: Charl Devenish

The use of land and the economics of Southern Africa at present is a contentious subject at almost every level of society. A historian and researcher who revels in happenings in these two areas, is Dr Admire Mseba, a postdoctoral research fellow in the International Studies Group (ISG) at the UFS.

Dr Mseba grew up in the Mberengwa region in southern Zimbabwe, known for cattle farming and mineral mining. While at the University of Zimbabwe, he became interested in economic history and archaeology, and completed his PhD at the University of Iowa in the USA. During his time there, Dr Mseba also became passionate about environmental history.

A historian's ability to think and engage critically on diverse subjects drew Dr Mseba to his field. Currently, he is busy with three research projects. Firstly, he is working on a book on social relations, about access to land in Zimbabwe. He is also examining regional and national efforts to control migratory pests during the 20th century, in particular, the red locust. In collaboration with a colleague at the ISG, Dr Mseba is also researching monetary systems in central Africa, covering the present-day countries of Zimbabwe, Malawi, and Zambia.

Dr Mseba believes future research opportunities in the domains of economic and environmental history abound. For one, the land question has been very topical in Zimbabwe for more than a decade—as it is now in South Africa—and needs more scrutiny. Regarding agrarian pestilences, he indicates the recent phenomenon of armyworm invasion. “There are so many opportunities for historians to investigate. There are so many ways to think about these things and trying to put it in perspective.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept